Advertisement
Advertisement

PROK

PROK logo

ProKidney Corp - Class A

1.77
USD
-0.08
-4.32%
Dec 18, 12:56 UTC -5
Open

ProKidney Corp - Class A Profile

About

ProKidney LP is a late clinical-stage cellular therapeutics company focused on CKD. The company's lead product candidate includes REACT(TM) is a first-of-its-kind, patented disease-modifying autologous cellular therapy. ProKidney LP, formerly known as Suvretta Holdings Corp. III, is based in WINSTON-SALEM, N,C.

Info & Links

CEO

Bruce Culleton

Headquarters

2000 FRONTIS PLAZA,SUITE 250
WINSTON-SALEM, NC 27103, UNITED STATES

Industry

Biotechnology

Sector

Health Technology

Website

www.prokidney.com

Auditor

Ernst & Young LLP

Share holders

42

Employees

163

ProKidney Corp - Class A Statistics

Valuation Measures

Market Capitalization2

621.24M

Enterprise Value

513.15M

Enterprise Value/EBITDA(ttm)

-3.39

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

13.34%

Return on Assets(ttm)

-10.24%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-151.31M

Net Income Available to Common(ttm)

-45.61M

Diluted EPS(ttm)

-0.55

Share Statistics

Beta (5Y Monthly)

1.27

52-Week Change

16.45%

S&P 500 52-Week Change

27.84%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

291.66M

Dividend Yield

0.00%

Float4

170.65M

% Held by Insiders

41.49%

% Held by Institutions

51.59%

Balance Sheet

Total Cash(mrq)

406.81M

Total Cash Per Share(mrq)

1.39

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

17.09%

Quick Ratio(mrq)

17.09%

Book Value Per Share(mrq)

-3.36

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.81

Free Cash Flow(ytd)

-106.18M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement